{
    "2018-05-28": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Novartis: Patients On Entresto Report Improved Quality Of Life",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Entresto",
                        "Improved Quality Of Life"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-20",
                "original_text": "AstraZeneca's Imfinzi Improves Survival in Lung Cancer Study",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Imfinzi",
                        "Survival",
                        "Lung Cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-20",
                "original_text": "AstraZeneca's Imfinzi Improves Survival in Lung Cancer Study",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Imfinzi",
                        "Survival",
                        "Lung Cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-04-10",
                "original_text": "Levnima Could Be Merckâ€™s Long-Term Growth Driver",
                "features": {
                    "keywords": [
                        "Levnima",
                        "Merck",
                        "Long-Term Growth"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}